FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1059-1064 April 10, 1997 Number 15 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Hepatitis-associated aplastic anemia is a variant of aplastic anemia in which aplastic anemia follows an acute attack of hepatitis. The aplastic anemia, however, is often fatal if untreated. To characterize the illness, investigate the role of hepatitis viruses, and assess the response to immunosuppressive treatment, we studied patients with the syndrome who were referred to the National Institutes of Health (NIH).

Methods Standard hematologic and biochemical tests and measurements of bone marrow cellularity were used to monitor the patients' response to treatment. Serum was assayed for antibodies and antigens related to hepatitis A, B, and C viruses and for the RNA of hepatitis C and GB virus C by the polymerase chain reaction. All patients were treated with antithymocyte globulin and cyclosporine.

Results Ten patients with hepatitis-associated aplastic anemia were referred to the NIH between 1990 and 1996; all had the typical features of this syndrome. There was evidence of activated CD8 T lymphocytes in the blood. Serologic tests for hepatitis A, B, and C viruses were negative; RNA of hepatitis C virus was undetectable in all patients, but RNA of GB virus C was detected in three patients. Seven of the patients responded to intensive immunosuppressive treatment; the three who did not respond all died within one year of treatment, two from complications of stem-cell or marrow transplantation.

Conclusions The hepatitis of the hepatitis-associated aplastic anemia does not appear to be caused by any of the known hepatitis viruses. We recommend immunosuppressive treatment for patients who do not have an HLA-matched related donor available for bone marrow transplantation. Several features of the syndrome suggest that it is mediated by immunopathologic mechanisms.

Source Information

From the Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Md.

Address reprint requests to Dr. Brown at Bldg. 10, Rm. 7C218, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892-1652.

Full Text of this Article

Related Letters:

Hepatitis-Associated Aplastic Anemia
Kiem H.-P., Storb R., McDonald G. B., Brown K. E., Young N. S.
Extract | Full Text  
N Engl J Med 1997; 337:424-425, Aug 7, 1997. Correspondence

This article has been cited by other articles:

• Lund, T., Tolar, J., Alexander, S. I., Reddel, R. R., Stormon, M. O. (2008). Chimerism and Tolerance in a Recipient of a Deceased-Donor Liver Transplant. NEJM 358: 2075-2075 [Full Text]  
• Osugi, Y., Yagasaki, H., Sako, M., Kosaka, Y., Taga, T., Ito, T., Yamamoto, M., Ohara, A., Sato, T., Mimaya, J., Tsukimoto, I., Kojima, S., the Japan Childhood Aplastic Anemia Study Group, (2007). Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia. haematol 92: 1687-1690 [Abstract] [Full Text]  
• Cantor, A. B., Shimamura, A. (2007). Cellular basis of hematopoiesis and marrow failure syndromes. ASH-SAP 2007: 23-44 [Full Text]  
• Sepulveda, E., Brethauer, U., Rojas, J., Le Fort, P. (2006). Oral manifestations of aplastic anemia in children. Journal of the American Dental Association 137: 474-478 [Abstract] [Full Text]  
• Issaragrisil, S., Kaufman, D. W., Anderson, T., Chansung, K., Leaverton, P. E., Shapiro, S., Young, N. S. (2006). The epidemiology of aplastic anemia in Thailand. Blood 107: 1299-1307 [Abstract] [Full Text]  
• Maciejewski, J. P., Risitano, A. M. (2005). Aplastic Anemia: Management of Adult Patients. ASH Education Book 2005: 110-117 [Abstract] [Full Text]  
• Lu, J., Basu, A., Melenhorst, J. J., Young, N. S., Brown, K. E. (2004). Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood 103: 4588-4593 [Abstract] [Full Text]  
• Hirano, N., Butler, M. O., von Bergwelt-Baildon, M. S., Maecker, B., Schultze, J. L., O'Connor, K. C., Schur, P. H., Kojima, S., Guinan, E. C., Nadler, L. M. (2003). Autoantibodies frequently detected in patients with aplastic anemia. Blood 102: 4567-4575 [Abstract] [Full Text]  
• Sloand, E., Kim, S., Maciejewski, J. P., Tisdale, J., Follmann, D., Young, N. S. (2002). Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 100: 1185-1191 [Abstract] [Full Text]  
• Young, N. S. (2002). Acquired Aplastic Anemia. ANN INTERN MED 136: 534-546 [Abstract] [Full Text]  
• Handa, A., Brown, K. E. (2000). GB virus C/hepatitis G virus replicates in human haematopoietic cells and vascular endothelial cells. J. Gen. Virol. 81: 2461-2469 [Abstract] [Full Text]  
• Kojima, S., Hibi, S., Kosaka, Y., Yamamoto, M., Tsuchida, M., Mugishima, H., Sugita, K., Yabe, H., Ohara, A., Tsukimoto, I. (2000). Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 96: 2049-2054 [Abstract] [Full Text]  
• Ben-Ari, Z., Samuel, D., Zemel, R., Baruch, Y., Gigou, M., Sikuler, E., Tur-Kaspa, R. (2000). Fulminant Non-A-G Viral Hepatitis Leading to Liver Transplantation. Arch Intern Med 160: 388-392 [Abstract] [Full Text]  
• Young, N. S., Abkowitz, J. L., Luzzatto, L. (2000). New Insights into the Pathophysiology of Acquired Cytopenias. ASH Education Book 2000: 18-38 [Abstract] [Full Text]  
• Young, N. S. (1999). Acquired Aplastic Anemia. JAMA 282: 271-278 [Full Text]  
• Crespo, J, de las Heras, B, Rivero, M, Lozano, J L, Fábrega, E, Pons-Romero, F (1999). Hepatitis G virus infection as a possible causative agent of community-acquired hepatitis and associated aplastic anaemia. Postgrad. Med. J. 75: 159-161 [Abstract] [Full Text]  
• Sansonno, D., Lotesoriere, C., Cornacchiulo, V., Fanelli, M., Gatti, P., Iodice, G., Racanelli, V., Dammacco, F. (1998). Hepatitis C Virus Infection Involves CD34+ Hematopoietic Progenitor Cells in Hepatitis C Virus Chronic Carriers. Blood 92: 3328-3337 [Abstract] [Full Text]  
• Binder, D., van den Broek, M. F., Kagi, D., Bluethmann, H., Fehr, J., Hengartner, H., Zinkernagel, R. M. (1998). Aplastic Anemia Rescued by Exhaustion of Cytokine-secreting CD8+ T Cells in Persistent Infection with Lymphocytic Choriomeningitis Virus. J. Exp. Med. 187: 1903-1920 [Abstract] [Full Text]  
• Hasegawa, D., Kojima, S., Tatsumi, E., Hayakawa, A., Kosaka, Y., Nakamura, H., Sako, M., Osugi, Y., Nagata, S., Sano, K. (1998). Elevation of the Serum Fas Ligand in Patients With Hemophagocytic Syndrome and Diamond-Blackfan Anemia. Blood 91: 2793-2799 [Abstract] [Full Text]  
• Kiem, H.-P., Storb, R., McDonald, G. B., Brown, K. E., Young, N. S. (1997). Hepatitis-Associated Aplastic Anemia. NEJM 337: 424-425 [Full Text]  
• Kiem, H.-P., Myerson, D., Storb, R., McDonald, G. B., Spurgeon, C. L., Leisenring, W. (1997). Prevalence of Hepatitis G Virus in Patients With Aplastic Anemia. Blood 90: 1335-1336 [Full Text]  
• Young, N. S., Maciejewski, J. (1997). The Pathophysiology of Acquired Aplastic Anemia. NEJM 336: 1365-1372 [Full Text]